Lyell Immunopharma Inc.
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About Lyell Immunopharma Inc.
Lyell Immunopharma Inc is a clinical-stage cell therapy company. It has a pipeline of product candidates for patients with solid tumors utilizing ex vivo genetic and epigenetic T-cell reprogramming technologies. The company's product pipeline includes, LYL797, LYL119, LYL845 among others.
/ 
Frequently asked questions
To buy Lyell Immunopharma Inc. stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for Lyell Immunopharma Inc. by name or ticker, choose the number of shares, and place your order.
The ticker symbol for Lyell Immunopharma Inc. is LYEL:xnas. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
Lyell Immunopharma Inc. has its primary listing on NASDAQ. You can trade Lyell Immunopharma Inc. with a Saxo account, alongside thousands of other stocks worldwide.
Yes, Lyell Immunopharma Inc. is available to trade on SaxoInvestor and SaxoTraderGO. You can buy shares directly and include Lyell Immunopharma Inc. as part of a broader investment portfolio. Explore our SaxoInvestor platform.
Learn more about investing and trading at Saxo’s educational content hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures— so you can make more informed decisions when considering shares like Lyell Immunopharma Inc..